文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

CpG oligodeoxynucleotide-coated chitosan nanoparticles enhance macrophage proinflammatory phenotype in vitro.

作者信息

Karami Fatemeh, Namdar Ahmadabad Hassan, Shaheli Marjan

机构信息

Biology, Arsanjan Branch, Azad University, Arsanjan, Iran.

Vector-borne Diseases Research Center, North Khorasan University of Medical Science, Bojnurd, Iran.

出版信息

Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae081.


DOI:10.1093/cei/uxae081
PMID:39250756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11754863/
Abstract

This study aimed to investigate the effects of CpG oligodeoxynucleotide (CpG-ODNs)-coated chitosan nanoparticles (CNP) on the phenotype of murine macrophages and their proinflammatory cytokine profile in vitro. CNP-CpG-ODNs loaded with FITC-scrambled siRNA were prepared using the ionotropic gelation method. Peritoneal macrophages were isolated and exposed to CNP-CpG-ODNs. Treated macrophages were assessed for uptake capacity. Flow cytometry was used to evaluate the expression levels of MHC-II, CD40, and CD86 costimulatory molecules in treated macrophages. Furthermore, the secretion levels of proinflammatory cytokines (TNF-α and IL-6) and the release of nitric oxide (NO) were measured in the culture supernatant of treated macrophages using sandwich ELISA and the Griess reaction, respectively. These in vitro studies showed that CNP-CpG-ODNs had no cytotoxic effect on macrophages and were efficiently taken up by them. Additionally, CNP-CpG-ODNs significantly increased the production of TNF-α, IL-6, and NO in the culture supernatant compared to CNP alone. Moreover, CNP-CpG-ODNs enhanced the expression of MHC-II, CD40, and CD86 costimulatory molecules on macrophages. These findings indicate that incorporating CpG-ODNs into CNPs promotes macrophage maturation and a proinflammatory phenotype. Therefore, CNP-CpG-ODNs may serve as an effective system for targeted gene delivery to macrophages, enhancing immune responses.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b207/11754863/0fbf0e94f6f6/uxae081_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b207/11754863/0fbf0e94f6f6/uxae081_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b207/11754863/0fbf0e94f6f6/uxae081_fig5.jpg

相似文献

[1]
CpG oligodeoxynucleotide-coated chitosan nanoparticles enhance macrophage proinflammatory phenotype in vitro.

Clin Exp Immunol. 2025-1-21

[2]
Effect of Ganoderma lucidum on cytokine release by peritoneal macrophages.

Iran J Immunol. 2007-12

[3]
Sequential macrophage DENV and ZIKV infection shows differential expression of CD86, IFN-β, and regulation of TNF-α and IL-1β depending on DENV serotype.

Braz J Microbiol. 2025-6

[4]
Leptin Enhances M1 Macrophage Polarization and Impairs Tendon-Bone Healing in Rotator Cuff Repair: A Rat Model.

Clin Orthop Relat Res. 2025-5-1

[5]
Macrophage IL-4 polarization is restricted by soluble CD40 agonists and antigen-induced CD154 but not by constitutive CD154 expressed by CD4+ T cells.

J Leukoc Biol. 2025-7-9

[6]
Influence of hexadecylphosphocholine on the release of tumor necrosis factor and nitroxide from peritoneal macrophages in vitro.

J Cancer Res Clin Oncol. 1995

[7]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[8]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2021-4-19

[9]
DS-Modified Paeoniflorin pH-Responsive Lipid-Polymer Hybrid Nanoparticles for Targeted Macrophage Polarization in a Rat Model of Rheumatoid Arthritis.

Int J Nanomedicine. 2025-7-12

[10]
Passive physical barrier modulates UVB-induced METosis-related MPO expression and activity, 25-hydroxyvitamin D3-1alpha-hydroxylase, and the shift of tissue-resident macrophages toward M1-associated iNOS.

Front Immunol. 2025-8-14

本文引用的文献

[1]
Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment.

J Nanobiotechnology. 2022-12-27

[2]
Targeting the Second Transferrin Receptor as Emerging Therapeutic Option for β-Thalassemia Major.

Hemasphere. 2022-10-28

[3]
Macrophages as tools and targets in cancer therapy.

Nat Rev Drug Discov. 2022-11

[4]
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy.

Kidney Dis (Basel). 2021-9-28

[5]
Macrophage-based Cell Strategies: A Novel Approach in Immunotherapy.

Hemasphere. 2022-2-4

[6]
Analysis of clinical trials on biomaterial and therapeutic applications of chitosan: A review.

Carbohydr Polym. 2022-2-15

[7]
Improvement in phenotype homeostasis of macrophages by chitosan nanoparticles and subsequent impacts on liver injury and tumor treatment.

Carbohydr Polym. 2022-2-1

[8]
Nanotechnology-based products for cancer immunotherapy.

Mol Biol Rep. 2022-2

[9]
Immunomodulatory potential of chitosan-based materials for cancer therapy: a systematic review of , and clinical studies.

Biomater Sci. 2021-5-4

[10]
The evolution of commercial drug delivery technologies.

Nat Biomed Eng. 2021-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索